SecSonar.com

Phreesia, Inc. (PHR)

Phreesia, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Phreesia, Inc. (PHR) is a Medical - Healthcare Information Services company based in US with a market capitalization of $606.6M. Revenue grew 14.5% year-over-year and the company generated $67.7M in free cash flow. This page tracks PHR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2.08K employees · IPO Jul 18, 2019

Valuation

Valuation & price

$8.77 · as of May 17, 2026 · -73.1% vs 52w high

233.9

P/E ratio

Latest-FY diluted EPS

1.80

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$31.99$20.04$8.09Jul 25Dec 25Jul 26Jul 7, 25$28.39Jul 9, 25$28.96Jul 11, 25$26.72Jul 15, 25$26.73Jul 17, 25$25.93Jul 21, 25$26.55Jul 23, 25$27.69Jul 25, 25$26.63Jul 29, 25$27.12Jul 31, 25$26.96Aug 4, 25$27.28Aug 6, 25$27.11Aug 11, 25$27.13Aug 13, 25$28.65Aug 15, 25$28.70Aug 19, 25$28.25Aug 21, 25$28.76Aug 25, 25$30.39Aug 27, 25$31.99Aug 29, 25$31.66Sep 3, 25$30.44Sep 5, 25$28.13Sep 9, 25$26.55Sep 11, 25$25.48Sep 16, 25$23.50Sep 18, 25$24.19Sep 22, 25$24.74Sep 24, 25$23.66Sep 26, 25$23.62Sep 30, 25$23.52Oct 2, 25$22.84Oct 6, 25$23.48Oct 8, 25$23.25Oct 10, 25$22.26Oct 14, 25$22.90Oct 16, 25$22.75Oct 21, 25$23.11Oct 23, 25$23.49Oct 27, 25$23.47Oct 29, 25$23.22Oct 31, 25$22.64Nov 4, 25$22.54Nov 6, 25$22.27Nov 10, 25$22.62Nov 12, 25$23.15Nov 14, 25$21.77Nov 18, 25$19.60Nov 20, 25$19.05Nov 25, 25$20.62Nov 28, 25$20.49Dec 2, 25$20.15Dec 4, 25$20.55Dec 8, 25$20.12Dec 10, 25$15.78Dec 12, 25$16.25Dec 16, 25$16.35Dec 18, 25$16.41Dec 22, 25$16.47Dec 24, 25$16.81Dec 29, 25$17.00Jan 2, 26$16.30Jan 6, 26$17.24Jan 8, 26$16.90Jan 12, 26$17.14Jan 14, 26$16.11Jan 16, 26$16.39Jan 21, 26$15.62Jan 23, 26$15.84Jan 27, 26$15.19Jan 29, 26$13.95Feb 2, 26$13.21Feb 4, 26$12.83Feb 9, 26$12.22Feb 11, 26$12.50Feb 13, 26$11.95Feb 18, 26$12.10Feb 20, 26$12.71Feb 24, 26$11.66Feb 26, 26$12.33Mar 2, 26$12.27Mar 4, 26$12.63Mar 6, 26$12.05Mar 10, 26$11.75Mar 12, 26$11.00Mar 17, 26$11.19Mar 19, 26$11.77Mar 23, 26$11.80Mar 25, 26$11.28Mar 27, 26$10.98Mar 31, 26$8.38Apr 2, 26$8.37Apr 7, 26$9.06Apr 9, 26$8.09Apr 13, 26$8.56Apr 15, 26$9.06Apr 17, 26$9.17Apr 22, 26$9.32Apr 24, 26$9.54Apr 28, 26$9.42Apr 30, 26$9.21May 4, 26$9.67May 6, 26$9.53May 8, 26$10.17May 12, 26$9.61May 14, 26$8.77May 18, 26$9.08May 20, 26$8.85May 22, 26$8.92May 28, 26$9.45Jun 1, 26$10.66Jun 3, 26$9.65Jun 5, 26$9.54Jun 9, 26$9.29Jun 11, 26$9.05Jun 15, 26$9.15Jun 17, 26$9.35Jun 22, 26$8.92Jun 24, 26$9.59Jun 26, 26$10.07Jul 2, 26$10.94
$8.0652-week range$32.55
Loading valuation history…

Fundamentals

Key fundamentals

$606.6M

Market cap

14.5%

Revenue growth (YoY)

61.3%

Gross margin

$67.7M

Free cash flow (USD)

$28.6M

Net debt

3.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2026

FY 2018$79.8MFY 2019$99.9MFY 2020$124.8MFY 2021$148.7MFY 2022$213.2MFY 2023$280.9MFY 2024$356.3MFY 2025$419.8MFY 2026$480.6M
$79.8M$480.6M

Free cash flow by year

2018 → 2026

FY 2018$-23.1MFY 2019$-12.0MFY 2020$-11.5MFY 2021$-15.7MFY 2022$-105.5MFY 2023$-116.3MFY 2024$-57.5MFY 2025$8.3MFY 2026$67.7M
-$23.1M$67.7M

Gross margin by year

2022 → 2026

FY 202261.8%FY 202361.1%FY 202465.2%FY 202567.9%FY 202661.3%
61.8%61.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last reported: May 27, 2026 (EPS $0.05)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $24K · 10b5-1 PlanEgbuonu-Davis Lisa · Director · $24.3KJun 26, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 24, 2026Filing
  • Quarterly report10-Q FiledMay 28, 2026Filing
  • 8-K eventEarnings ReleaseMay 27, 2026Filing
  • Insider sellInsider Sell $4K · 10b5-1 PlanHui Yvonne · Principal Accounting Officer · $3.8KMay 20, 2026Filing
  • 8-K eventRestructuringMay 11, 2026Filing
  • 8-K eventReceivables Agreement AmendmentMay 4, 2026Filing
  • Insider sellInsider Sell $56K · 10b5-1 PlanHoffman Allison C · General Counsel & Secretary · $56KApr 21, 2026Filing
  • Insider sellInsider Sell $12K · 10b5-1 PlanHui Yvonne · Principal Accounting Officer · $12.3KApr 21, 2026Filing
  • Insider sellInsider Sell $91K · 10b5-1 PlanHui Yvonne · Principal Accounting Officer · $91.4KApr 17, 2026Filing

Questions

Frequently asked questions

What is Phreesia, Inc.'s market cap?

Phreesia, Inc. (PHR) has a market capitalization of $606.6M.

What is PHR's P/E ratio?

PHR trades at a price-to-earnings ratio of 233.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PHR's price-to-book (P/B) ratio?

PHR trades at 1.80 times book value per share.

When did Phreesia, Inc. last report earnings?

PHR last reported earnings on May 27, 2026; the next date is not yet scheduled.

Are insiders buying PHR stock?

SEC Form 4 filings show no open-market insider buys at Phreesia, Inc. in the last 90 days (7 sells).

Same arena

Related companies in Medical - Healthcare Information Services

HSTM

HealthStream, Inc.

$738.3M

NRC

National Research Corporation

$449.9M

EVH

Evolent Health, Inc.

$443.7M

CTEV

Claritev Corporation

$428.8M

NUTX

Nutex Health, Inc.

$792.1M

TBRG

TruBridge, Inc.

$389.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.